Purpose: We assessed the signal of the globus pallidus (GP) in cases of hepatic insufficiency, especially to evaluate the degree of discrepancy in paramagnetic effects on shortening of T(1) and T(2)* using susceptibility-weighted images (SWI).

Materials And Methods: Seven patients with hepatic insufficiency underwent magnetic resonance (MR) examinations that included T(1)-weighted images (T(1)WI), T(2)-weighted images (T(2)WI), and SWI on a 1.5-tesla MR imager, and we compared their results to those of controls. On T(1)WI and T(2)WI, we measured signal intensity in the GP and posterior segment of the putamen (Put) to obtain a signal ratio (GP/Put ratio), and on SWI, we classified signal intensity into 4 grades: A, higher than the cortex; B, lower than the cortex and higher than the cerebrospinal fluid (CSF); C, lower than the CSF and higher than the red nucleus; and D, lower than the red nucleus.

Results: In the 7 patients with hepatic insufficiency, the mean GP/Put ratio was significantly higher on T(1)WI and T(2)WI than those values in controls. On SWI, we classified 2 cases each as Grade A, Grade B, and Grade C, and one as Grade D. Although the signal of the GP was elevated on T(1)WI, there was no decrease in signal on T(2)WI. On SWI, we obtained no low signal intensity.

Conclusion: In patients with hepatic insufficiency, the globus pallidus did not show low signal intensity on either T(2)WI or SWI. Hyperintensity of the GP on T(1)WI without hypointensity on T(2)WI, or even SWI, suggests a discrepancy between paramagnetic effect on T(1) and T(2) shortening that reflects the accumulation of manganese and the presence of hepatic insufficiency.

Download full-text PDF

Source
http://dx.doi.org/10.2463/mrms.10.79DOI Listing

Publication Analysis

Top Keywords

hepatic insufficiency
24
t2wi swi
16
globus pallidus
12
patients hepatic
12
signal intensity
12
grade grade
12
signal
8
discrepancy paramagnetic
8
t1wi t2wi
8
gp/put ratio
8

Similar Publications

Background: In July 2023, the OPTN adopted MELD3.0 to address sex-based disparities in liver transplantation (LT) opportunity and waitlist mortality. No studies have proven that MELD3.

View Article and Find Full Text PDF

Hepatic encephalopathy (HE) is a clinical syndrome that can result from acute and chronic liver disorders, such as hepatitis, liver failure caused by alcohol or drugs, autoimmune diseases, metabolic diseases, cirrhosis, different types of tumors, and infections. This study aimed to investigate the effects of different doses of Beta-myrcene (β-myrcene) on the improvement of HE caused by thioacetamide (TAC) in male rats. To induce liver failure and acute damage in the studied animals, TAC was administered to rats at a dose of 100 mg/kg of body weight through an intraperitoneal (IP) injection with 24-hour intervals for seven consecutive days.

View Article and Find Full Text PDF

Aims: Carboxylesterase (Ces)1f is implicated in protection against hepatic inflammation, but it is unclear whether the enzyme has an influence in polarization of Kupffer cells (KCs), the innate immune cells mediating hepatic inflammatory injury including acute liver failure (ALF). In the present study, we aim to explore KC polarization induced by Ces1f in mice with lipopolysaccharide/D-galactosamine (LPS/D-GalN)-induced ALF. We adopted a novel delivery system, β-1,3-D-glucan-encapsulated Endoporter-siRNA particles, to specifically target KC Ces1f knockdown via tail vein injection in mice.

View Article and Find Full Text PDF

Pediatric liver transplantation (PLT) is a life-saving procedure for children with end-stage liver disease. However, post-transplant monitoring, particularly the diagnosis and prognosis of complications such as allograft fibrosis, remains challenging. Traditionally, liver biopsy has been the gold standard for assessing allograft fibrosis, despite its invasive nature and inherent procedural risks.

View Article and Find Full Text PDF

Objectives: To explore the role of the cGAS-STING signaling pathway in the therapeutic mechanism of Formula (LXJDHYF) for acute-on-chronic liver failure (ACLF) in mice.

Methods: Thirty C57BL/6 mice were randomly divided into blank control group, model group, low- and high-dose LXJDHYF groups, and H151 (a specific cGAS-STING pathway inhibitor) group (6). In all but the control group, the mice were treated with CCl to induce liver cirrhosis followed by intraperitoneal injections of lipopolysaccharide and D-amino galactose to establish mouse models of ACLF.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!